Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for AtriCure (ATRC) over the last 12 years, with Q3 2021 value amounting to $82.3 million.

  • AtriCure's Asset Writedowns and Impairment changed N/A to $82.3 million in Q3 2021 from the same period last year, while for Dec 2022 it was $82.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $82.3 million for FY2021, which is N/A changed from last year.
  • AtriCure's Asset Writedowns and Impairment amounted to $82.3 million in Q3 2021.
  • In the past 5 years, AtriCure's Asset Writedowns and Impairment ranged from a high of $82.3 million in Q3 2021 and a low of -$580000.0 during Q4 2019
  • In the last 4 years, AtriCure's Asset Writedowns and Impairment had a median value of $7000.0 in 2018 and averaged $9.2 million.
  • As far as peak fluctuations go, AtriCure's Asset Writedowns and Impairment tumbled by 10785.34% in 2017, and later skyrocketed by 250666.67% in 2018.
  • AtriCure's Asset Writedowns and Impairment (Quarter) stood at -$15000.0 in 2017, then skyrocketed by 2506.67% to $361000.0 in 2018, then crashed by 260.66% to -$580000.0 in 2019, then surged by 14289.66% to $82.3 million in 2021.
  • Its Asset Writedowns and Impairment was $82.3 million in Q3 2021, compared to -$580000.0 in Q4 2019 and $512000.0 in Q3 2019.